Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease
Olivier Govaere,Sine Kragh Petersen,Nuria Martinez-Lopez,Jasper Wouters,Matthias Van Haele,Rosellina M. Mancina,Oveis Jamialahmadi,Orsolya Bilkei-Gorzo,Pierre Bel Lassen,Rebecca Darlay,Julien Peltier,Jeremy M. Palmer,Ramy Younes,Dina Tiniakos,Guruprasad P. Aithal,Michael Allison,Michele Vacca,Melker Göransson,Michael J Drinnan,Hannele Yki-Järvinen,Jean-Francois Dufour,Mattias Ekstedt,Sven Francque,Salvatore Petta,Elisabetta Bugianesi,Jörn M Schattenberg,Christopher P. Day,Heather J. Cordell,Baki Topal,Karine Clément,Stefano Romeo,Vlad Ratziu,Tania Roskams,Ann K. Daly,Quentin M. Anstee,Matthias Trost,Anetta Härtlova
DOI: https://doi.org/10.1101/2020.02.01.930115
2020-02-02
Abstract:Abstract Obesity-associated inflammation is a key player in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). However, the exact mechanisms remain incompletely understood. Here we demonstrate that macrophage scavenger receptor 1 (MSR1, CD204) expression is associated with the occurrence of hepatic lipid-laden foamy macrophages and correlates with the degree of steatosis and steatohepatitis in a cohort of 170 NAFLD patients. Mice lacking Msr1 are protected against high fat-cholesterol diet (HFD)-induced metabolic disorder, showing fewer hepatic lipid-laden foamy macrophages, less hepatic inflammation, improved dyslipidemia and glucose tolerance, while showing a change in hepatic lipid metabolism. We show that MSR1 induces a pro-inflammatory response via the JNK signaling pathway upon triggering by saturated fatty acids. In vitro blockade of the receptor prevented the accumulation of lipids in primary macrophages which inhibited the switch towards a pro-inflammatory phenotype and the release of cytokines such as TNFa. Targeting MSR1 using monoclonal antibody therapy in an obesity-associated NAFLD mouse model and ex vivo human liver slices resulted in the prevention of foamy macrophage formation and liver inflammation. Moreover, we identified that rs41505344, a polymorphism in the upstream transcriptional region of MSR1, was associated with altered serum triglycerides and aspartate transaminase levels in a cohort of over 400,000 patients. Taken together, our data suggest a critical role for MSR1 in lipid homeostasis and a potential therapeutic target for the treatment of NAFLD. One Sentence Summary The immunometabolic role of MSR1 in human NAFLD.